Sphingosine-1-phosphate evokes unique segment-specific vasoconstriction of the renal microvasculature

Journal of the American Society of Nephrology

Volumn 25, Issue 8, 2014, Pages 1774-1785

  Guan, Zhengrong ^a   Singletary, Sean T ^a   Cook, Anthony K ^a   Hobbs, Janet L ^a   Pollock, Jennifer S ^a   Inscho, Edward W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; ALPHA SMOOTH MUSCLE ACTIN; CALCIUM CHANNEL L TYPE; DILTIAZEM; FINGOLIMOD; NIFEDIPINE; SPHINGOSINE 1 PHOSPHATE; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1-PHOSPHATE;

ANIMAL CELL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HELA CELL LINE; HOMOGENATE; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY MICROVASCULATURE; MALE; MICROVASCULATURE; NEPHRON; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SMOOTH MUSCLE FIBER; VASOCONSTRICTION; WESTERN BLOTTING; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; KIDNEY CIRCULATION; METABOLISM; MICROCIRCULATION; SPRAGUE DAWLEY RAT; TISSUE CULTURE TECHNIQUE; VASCULARIZATION;

ANIMALS; ARTERIOLES; LYSOPHOSPHOLIPIDS; MALE; MICROCIRCULATION; NEPHRONS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LYSOSPHINGOLIPID; RENAL CIRCULATION; SPHINGOSINE; TISSUE CULTURE TECHNIQUES; VASOCONSTRICTION;

EID: 84901265260     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013060656     Document Type: Article

References (54)

1. Maceyka M, Milstien S, Spiegel S: Sphingosine-1-phosphate: The Swiss armyknife of sphingolipid signaling.JLipidRes 50[Suppl]: S272-S276, 2009
2. Alvarez SE, Milstien S, Spiegel S: Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab 18: 300-307, 2007
3. Hla T, Venkataraman K, Michaud J: The vascular S1P gradient-cellular sources and biological significance. Biochim Biophys Acta 1781: 477-482, 2008
4. Igarashi J, Michel T: Sphingosine-1-phosphate and modulation of vascular tone. Cardiovasc Res 82: 212-220, 2009
5. Kim RH, Takabe K, Milstien S, Spiegel S: Export and functions of sphingosine-1-phosphate. BiochimBiophys Acta 1791: 692-696, 2009
6. Yatomi Y: Plasma sphingosine 1-phosphate metabolism and analysis. Biochim Biophys Acta 1780: 606-611, 2008
7. Venkataraman K, Lee YM, Michaud J, Thangada S, Ai Y, Bonkovsky HL, ParikhNS,Habrukowich C, Hla T: Vascular endotheliumas a contributor of plasma sphingosine 1-phosphate. Circ Res 102: 669-676, 2008
8. Goetzl EJ, Wang W, McGiffert C, Liao JJ, Huang MC: Sphingosine 1-phosphate as an intracellular messenger and extracellular mediator in immunity. Acta Paediatr Suppl 96: 49-52, 2007
9. Meyer zu Heringdorf D, LiliomK, SchaeferM, Danneberg K, Jaggar JH, Tigyi G, Jakobs KH: Photolysis of intracellular caged sphingosine-1-phosphate causes Ca2+ mobilization independently of G-protein-coupled receptors. FEBS Lett 554: 443-449, 2003
10. Sanchez T, Hla T: Structural and functional characteristics of S1P receptors. J Cell Biochem 92: 913-922, 2004
11. Imasawa T, Kitamura H, Ohkawa R, Satoh Y, Miyashita A, Yatomi Y: Unbalanced expression of sphingosine 1-phosphate receptors in diabetic nephropathy. Exp Toxicol Pathol 62: 53-60, 2010
12. Zhu Q, Xia M, Wang Z, Li PL, Li N: A novel lipid natriuretic factor in the renal medulla: Sphingosine-1-phosphate. Am J Physiol Renal Physiol 301: F35-F41, 2011
13. Bautista-Pérez R, Arellano A, Franco M, Osorio H, Coronel I: Sphingosine-1-phosphate induced vasoconstriction is increased in the isolated perfused kidneys of diabetic rats. Diabetes Res Clin Pract 94: e8-e11, 2011
14. Bischoff A, Czyborra P, Fetscher C, Meyer Zu Heringdorf D, Jakobs KH, Michel MC: Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal andmesentericmicrovessels in vitro. Br J Pharmacol 130: 1871-1877, 2000
15. Bischoff A, Czyborra P,Meyer Zu Heringdorf D, Jakobs KH,MichelMC: Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitivemanner. Br J Pharmacol 130: 1878-1883, 2000
16. Lorenz JN, Arend LJ, Robitz R, Paul RJ, MacLennan AJ: Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockoutmice.Am J Physiol Regul Integr Comp Physiol 292: R440-R446, 2007
17. Jo SK, Bajwa A, Awad AS, Lynch KR, Okusa MD: Sphingosine-1-phosphate receptors: Biology and therapeutic potential in kidney disease. Kidney Int 73: 1220-1230, 2008
18. Krämer S, Binder E, Loof T,Wang-Rosenke Y,Martini S, Khadzhynov D, Budde K, Neumayer HH, Peters H: The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy. Am J Physiol Renal Physiol 297: F218-F227, 2009
19. Awad AS, Ye H, Huang L, Li L, Foss FW Jr, Macdonald TL, Lynch KR, Okusa MD: Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 290: F1516-F1524, 2006
20. Park SW, Kim M, Brown KM, D'Agati VD, Lee HT: Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 23: 266-280, 2012
21. Bajwa A, Jo SK, Ye H, Huang L, Dondeti KR, Rosin DL, Haase VH, Macdonald TL, Lynch KR, Okusa MD: Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemiareperfusion injury. J Am Soc Nephrol 21: 955-965, 2010
22. Billich A, Bornancin F, Dévay P, Mechtcheriakova D, Urtz N, Baumruker T: Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J Biol Chem 278: 47408-47415, 2003
23. Carmines PK, Fowler BC, Bell PD: Segmentally distinct effects of depolarization on intracellular [Ca2+] in renal arterioles. Am J Physiol 265: F677-F685, 1993
24. Conger JD, Falk SA: KCl and angiotensin responses in isolated rat renal arterioles: Effects of diltiazem and low-calcium medium. Am J Physiol 264: F134-F140, 1993
25. Inscho EW,MasonMJ, SchroederAC,Deichmann PC, Stiegler KD, Imig JD: Agonist-induced calcium regulation in freshly isolated renal microvascular smooth muscle cells. J Am Soc Nephrol 8: 569-579, 1997
26. Salomonsson M, Sorensen CM, ArendshorstWJ, Steendahl J, Holstein-Rathlou NH: Calciumhandling in afferent arterioles. Acta Physiol Scand 181: 421-429, 2004
27. Salomone S, Potts EM, Tyndall S, Ip PC, Chun J, Brinkmann V, Waeber C: Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. Br J Pharmacol 153: 140-147, 2008
28. Salomone S, Yoshimura S, Reuter U, Foley M, Thomas SS, Moskowitz MA, Waeber C: S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. Eur J Pharmacol 469: 125-134, 2003
29. Choi SK, Ahn DS, Lee YH: Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery. Cardiovasc Res 82: 324-332, 2009
30. Bolz SS, Vogel L, Sollinger D, Derwand R, Boer C, Pitson SM, Spiegel S, Pohl U: Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase. Circulation 108: 342-347, 2003
31. KellerM, Lidington D, Vogel L, Peter BF, Sohn HY, Pagano PJ, Pitson S, Spiegel S, Pohl U, Bolz SS: Sphingosine kinase functionally links elevated transmural pressure and increased reactive oxygen species formation in resistance arteries. FASEB J 20: 702-704, 2006
32. Ohmori T, Yatomi Y, Osada M, Kazama F, Takafuta T, Ikeda H, Ozaki Y: Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc Res 58: 170-177, 2003
33. Cyster JG, Schwab SR: Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol 30: 69-94, 2012
34. Venkataraman K, Thangada S, Michaud J, Oo ML, Ai Y, Lee YM,Wu M, Parikh NS, Khan F, Proia RL, Hla T: Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem J 397: 461-471, 2006
35. Inscho EW, Imig JD, Cook AK: Afferent and efferent arteriolar vasoconstriction to angiotensin II and norepinephrine involves release of Ca2+ from intracellular stores. Hypertension 29: 222-227, 1997
36. Lee MJ, Van Brocklyn JR, Thangada S, Liu CH, Hand AR, Menzeleev R, Spiegel S, Hla T: Sphingosine-1-phosphate as a ligand for the G proteincoupled receptor EDG-1. Science 279: 1552-1555, 1998
37. Coussin F, Scott RH, Wise A, Nixon GF: Comparison of sphingosine 1-phosphate-induced intracellular signalingpathways invascular smooth muscles: Differential role in vasoconstriction. Circ Res 91: 151-157, 2002
38. Peter BF, Lidington D, Harada A, Bolz HJ, Vogel L, Heximer S, Spiegel S, Pohl U, Bolz SS: Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone. Circ Res 103: 315-324, 2008
39. Ota H, Beutz MA, Ito M, Abe K, Oka M, McMurtry IF: S1P(4) receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs. Pulm Circ 1: 399-404, 2011
40. Igarashi J, Erwin PA, Dantas AP, Chen H, Michel T: VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors. Proc Natl Acad Sci U S A 100: 10664-10669, 2003
41. Osada M, Yatomi Y, Ohmori T, Ikeda H, Ozaki Y: Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem Biophys Res Commun 299: 483-487, 2002
42. Lim M, Choi SK, Cho YE, Yeon SI, Kim EC, Ahn DS, Lee YH: The role of sphingosine kinase 1/sphingosine-1-phosphate pathway in the myogenic tone of posterior cerebral arteries. PLoS ONE 7: e35177, 2012
43. Tanimoto T, Lungu AO, Berk BC: Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smoothmuscle cells. Circ Res 94: 1050-1058, 2004
44. Bischoff A, Finger J, Michel MC: Nifedipine inhibits sphinogosine-1-phosphate-induced renovascular contraction in vitro and in vivo. Naunyn Schmiedebergs Arch Pharmacol 364: 179-182, 2001
45. Inscho EW, Cook AK, Webb RC, Jin LM: Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter. Am J Physiol Renal Physiol 296: F590-F597, 2009
46. Arendshorst WJ, Thai TL: Regulation of the renal microcirculation by ryanodine receptors and calcium-induced calcium release. Curr Opin Nephrol Hypertens 18: 40-49, 2009
47. Inscho EW, Imig JD, Cook AK, Pollock DMET: ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin. Br J Pharmacol 146: 1019-1026, 2005
48. Ikenaga H, Fallet RW, Carmines PK: Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANG II in rat kidney. Am J Physiol 271: F365-F373, 1996
49. Guan Z, Giddens MI, Osmond DA, Cook AK, Hobbs JL, Zhang S, Yamamoto T, Pollock JS, Pollock DM, Inscho EW: Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity inANGII-hypertensive rats.AmJ Physiol Renal Physiol 304: F801-F807, 2013
50. Inscho EW, Cook AK, Clarke A, Zhang S, Guan Z: P2X1 receptormediated vasoconstriction of afferent arterioles in angiotensin II-infused hypertensive rats fed a high-salt diet. Hypertension 57: 780-787, 2011
51. Guan Z, Pollock JS, Cook AK, Hobbs JL, Inscho EW: Effect of epithelial sodium channel blockade on themyogenic response of rat juxtamedullary afferent arterioles. Hypertension 54: 1062-1069, 2009
52. Albert R, Hinterding K, Brinkmann V, Guerini D, Müller-Hartwieg C, Knecht H, Simeon C, Streiff M, Wagner T, Welzenbach K, Zécri F, ZollingerM, Cooke N, Francotte E: Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer. J Med Chem48: 5373-5377, 2005
53. Zhao X, Cook AK, Field M, Edwards B, Zhang S, Zhang Z, Pollock JS, Imig JD, Inscho EW: Impaired Ca2+ signaling attenuates P2X receptormediated vasoconstriction of afferent arterioles in angiotensin II hypertension. Hypertension 46: 562-568, 2005
54. Rodgers A, Mormeneo D, Long JS, Delgado A, Pyne NJ, Pyne S: Sphingosine 1-phosphate regulation of extracellular signal-regulated kinase-1/2 in embryonic stem cells. Stem Cells Dev 18: 1319-1330, 2009